Cisplatin — Dosing in CKD & Dialysis

Cisplatin (Antineoplastic): renal dosing adjustments, dialyzability (Not effectively removed: hemodialysis is not effective in overdose because of the high degree of protein binding), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology professionals.

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.